Lexicon Pharmaceuticals (LXRX) Goodwill (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Goodwill of $44.5 million for Q1 2026, little changed year-over-year from $44.5 million in Q1 2025, and little changed on a QoQ basis from $44.5 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) has 17 years of Goodwill data on file, last reported at $44.5 million in Q1 2026.
- Quarterly Goodwill changed 0.0% year-over-year to $44.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $44.5 million, changed 0.0% from the prior year.
- Goodwill held at $44.5 million in Q1 2026 per LXRX's latest filing, from $44.5 million in the prior quarter.
- Across five years, Goodwill topped out at $44.5 million in Q1 2022 and bottomed at $44.5 million in Q1 2022.
- The 5-year median for Goodwill is $44.5 million (2022), against an average of $44.5 million.
- Peak annual rise in Goodwill reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
- Tracing LXRX's Goodwill over 5 years: stood at $44.5 million in 2022, then changed by 0.0% to $44.5 million in 2023, then changed by 0.0% to $44.5 million in 2024, then changed by 0.0% to $44.5 million in 2025, then changed by 0.0% to $44.5 million in 2026.
- Per Business Quant, the three latest LXRX Goodwill figures stand at $44.5 million (Q1 2026), $44.5 million (Q4 2025), and $44.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lexicon Pharmaceuticals | 872.52 Mn | 701.87 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.54 Mn |
| Dec 31, 2025 | 44.54 Mn |
| Sep 30, 2025 | 44.54 Mn |
| Jun 30, 2025 | 44.54 Mn |
| Mar 31, 2025 | 44.54 Mn |
| Dec 31, 2024 | 44.54 Mn |
| Sep 30, 2024 | 44.54 Mn |
| Jun 30, 2024 | 44.54 Mn |
| Mar 31, 2024 | 44.54 Mn |
| Dec 31, 2023 | 44.54 Mn |
| Sep 30, 2023 | 44.54 Mn |
| Jun 30, 2023 | 44.54 Mn |
| Mar 31, 2023 | 44.54 Mn |
| Dec 31, 2022 | 44.54 Mn |
| Sep 30, 2022 | 44.54 Mn |
| Jun 30, 2022 | 44.54 Mn |
| Mar 31, 2022 | 44.54 Mn |
| Dec 31, 2021 | 44.54 Mn |
| Sep 30, 2021 | 44.54 Mn |
| Jun 30, 2021 | 44.54 Mn |
| Mar 31, 2021 | 44.54 Mn |
| Dec 31, 2020 | 44.54 Mn |
| Sep 30, 2020 | 44.54 Mn |
| Jun 30, 2020 | 44.54 Mn |
| Mar 31, 2020 | 44.54 Mn |
| Dec 31, 2019 | 44.54 Mn |
| Sep 30, 2019 | 44.54 Mn |
| Jun 30, 2019 | 44.54 Mn |
| Mar 31, 2019 | 44.54 Mn |
| Dec 31, 2018 | 44.54 Mn |
| Sep 30, 2018 | 44.54 Mn |
| Jun 30, 2018 | 44.54 Mn |
| Mar 31, 2018 | 44.54 Mn |
| Dec 31, 2017 | 44.54 Mn |
| Sep 30, 2017 | 44.54 Mn |
| Jun 30, 2017 | 44.54 Mn |
| Mar 31, 2017 | 44.54 Mn |
| Dec 31, 2016 | 44.54 Mn |
| Sep 30, 2016 | 44.54 Mn |
| Jun 30, 2016 | 44.54 Mn |
| Mar 31, 2016 | 44.54 Mn |
| Dec 31, 2015 | 44.54 Mn |
| Sep 30, 2015 | 44.54 Mn |
| Jun 30, 2015 | 44.54 Mn |
| Mar 31, 2015 | 44.54 Mn |
| Dec 31, 2014 | 44.54 Mn |
| Sep 30, 2014 | 44.54 Mn |
| Jun 30, 2014 | 44.54 Mn |
| Mar 31, 2014 | 44.54 Mn |
| Dec 31, 2013 | 44.54 Mn |
| Sep 30, 2013 | 44.54 Mn |
| Jun 30, 2013 | 44.54 Mn |
| Mar 31, 2013 | 44.54 Mn |
| Dec 31, 2012 | 44.54 Mn |
| Sep 30, 2012 | 44.54 Mn |
| Jun 30, 2012 | 44.54 Mn |
| Mar 31, 2012 | 44.54 Mn |
| Dec 31, 2011 | 44.54 Mn |
| Sep 30, 2011 | 44.54 Mn |
| Jun 30, 2011 | 44.54 Mn |
| Dec 31, 2010 | 44.54 Mn |